FDA Allows Marketing of First Device to Help with Opioid Withdrawal
The U.S. FDA has announced that it will permit marketing of the first product—an electric stimulation device dubbed the NSS-2 Bridge—for use in helping to reduce the symptoms of opioid withdrawal. This device is developed by Versailles, Ind.-based Innovative Health Solutions, Inc.
Read More